EIP
AGN

Easterly Investment Partners’s Allergan plc AGN Stock Holding History

Easterly Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,000
Closed -$708K – 116
2020
Q1 		$708K Hold
4,000
– – 0.03% 51
2019
Q4 		$765K Sell
4,000
-2,089
-34% -$377K 0.02% 58
2019
Q3 		$1.02M Buy
6,089
+2,490
+69% +$406K 0.03% 55
2019
Q2 		$603K Buy
+3,599
New +$498K 0.02% 68

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Easterly Investment Partners's AGN Position: Q2 2020 in Review

Easterly Investment Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,000 shares — an estimated $708K sold.

Easterly Investment Partners first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $1.02M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Easterly Investment Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Easterly Investment Partners sold 4,000 Allergan plc shares in Q2 2020, an estimated $708K.
  • Easterly Investment Partners first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Easterly Investment Partners's Allergan plc position peaked at $1.02M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Easterly Investment Partners's 13F filing for Q2 2020, filed 14 Aug 2020.